{"title":"侵袭性乳腺癌1例报告","authors":"Kundana Rayamajhi, R. Ghimire, B. Kayastha","doi":"10.3126/njr.v13i1.57833","DOIUrl":null,"url":null,"abstract":"Human epidermal growth factor receptor-2 (HER 2) positive breast cancers represent a highly aggressive breast cancer subtype and are associated witha worse prognosis. They tend to be more aggressive with lower survival rates but with a better prognosis than the triple-negative subtype.","PeriodicalId":178516,"journal":{"name":"Nepalese Journal of Radiology","volume":"10 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"A Case Report on Aggressive Breast Cancer\",\"authors\":\"Kundana Rayamajhi, R. Ghimire, B. Kayastha\",\"doi\":\"10.3126/njr.v13i1.57833\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Human epidermal growth factor receptor-2 (HER 2) positive breast cancers represent a highly aggressive breast cancer subtype and are associated witha worse prognosis. They tend to be more aggressive with lower survival rates but with a better prognosis than the triple-negative subtype.\",\"PeriodicalId\":178516,\"journal\":{\"name\":\"Nepalese Journal of Radiology\",\"volume\":\"10 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-06-30\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Nepalese Journal of Radiology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.3126/njr.v13i1.57833\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Nepalese Journal of Radiology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3126/njr.v13i1.57833","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Human epidermal growth factor receptor-2 (HER 2) positive breast cancers represent a highly aggressive breast cancer subtype and are associated witha worse prognosis. They tend to be more aggressive with lower survival rates but with a better prognosis than the triple-negative subtype.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
